Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy

Nature Structural and Molecular Biology

Volumn 23, Issue 10, 2016, Pages 899-905

  Walls, Alexandra C ^a   Tortorici, M Alejandra ^b,c   Frenz, Brandon ^a   Snijder, Joost ^a   Li, Wentao ^d   Rey, Félix A ^b,c   DiMaio, Frank ^a   Bosch, Berend Jan ^d   Veesler, David ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; B LYMPHOCYTE RECEPTOR; CD4 ANTIGEN; CORONAVIRUS SPIKE GLYCOPROTEIN; GLYCAN; NEUTRALIZING ANTIBODY; PROTEOHEPARAN SULFATE; EPITOPE; POLYSACCHARIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CORONAVIRIDAE; CRYOELECTRON MICROSCOPY; DROSOPHILA; IMMUNE EVASION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; ANIMAL; CELL LINE; CHEMISTRY; CORONAVIRUS INFECTION; HUMAN; HUMAN CORONAVIRUS NL63; IMMUNOLOGY; MOLECULAR MODEL; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINE; CORONAVIRUS INFECTIONS; CORONAVIRUS NL63, HUMAN; CRYOELECTRON MICROSCOPY; DROSOPHILA; EPITOPES; HUMANS; MODELS, MOLECULAR; POLYSACCHARIDES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SPIKE GLYCOPROTEIN, CORONAVIRUS;

EID: 84987652828     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.3293     Document Type: Article

References (76)

1. Zumla, A., Chan, J.F., Azhar, E.I., Hui, D.S., Yuen, K.Y. Coronaviruses: drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15, 327-347 (2016).
2. Vijay, R., Perlman, S. Middle East respiratory syndrome and severe acute respiratory syndrome. Curr. Opin. Virol. 16, 70-76 (2016).
3. Ge, X.Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535-538 (2013).
4. Sabir, J.S. et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351, 81-84 (2016).
5. Yang, Y. et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc. Natl. Acad. Sci. USA 111, 12516-12521 (2014).
6. Wang, Q. et al. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16, 328-337 (2014).
7. Yang, Y. et al. Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus. J. Virol. 89, 9119-9123 (2015).
8. van der Hoek, L. et al. Identification of a new human coronavirus. Nat. Med. 10, 368-373 (2004).
9. Fouchier, R.A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc. Natl. Acad. Sci. USA 101, 6212-6216 (2004).
10. Hofmann, H. et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. USA 102, 7988-7993 (2005).
11. Chiu, S.S. et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 40, 1721-1729 (2005).
12. Mole, B. Deadly pig virus slips through US borders. Nature 499, 388 (2013).
13. Du, L. et al. The spike protein of SARS-CoV: a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226-236 (2009).
14. Bosch, B.J., van der Zee, R., de Haan, C.A., Rottier, P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77, 8801-8811 (2003).
15. Burkard, C. et al. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog. 10, e1004502 (2014).
16. Millet, J.K., Whittaker, G.R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc. Natl. Acad. Sci. USA 111, 15214-15219 (2014).
17. Millet, J.K., Whittaker, G.R. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202, 120-134 (2015).
18. Walls, A.C. et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531, 114-117 (2016).
19. Li, X. et al. Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat. Methods 10, 584-590 (2013).
20. Scheres, S.H., Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853-854 (2012).
21. Rosenthal, P.B., Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721-745 (2003).
22. Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D Biol. Crystallogr. 71, 136-153 (2015).
23. DiMaio, F. et al. Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement. Nat. Methods 12, 361-365 (2015).
24. Wang, R.Y. et al. De novo protein structure determination from near-atomic-resolution cryo-EM maps. Nat. Methods 12, 335-338 (2015).
25. Song, Y. et al. High-resolution comparative modeling with RosettaCM. Structure 21, 1735-1742 (2013).
26. Frese, C.K. et al. Unambiguous phosphosite localization using electron-transfer/higher-energy collision dissociation (EThcD). J. Proteome Res. 12, 1520-1525 (2013).
27. Jeffers, S.A., Hemmila, E.M., Holmes, K.V. Human coronavirus 229E can use CD209L (L-SIGN) to enter cells. Adv. Exp. Med. Biol. 581, 265-269 (2006).
28. Ritchie, G. et al. Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein. Virology 399, 257-269 (2010).
29. Zhou, Y. et al. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J. Virol. 84, 8753-8764 (2010).
30. Jeffers, S.A. et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 101, 15748-15753 (2004).
31. Holm, L., Rosenström, P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545-W549 (2010).
32. Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., Matsuyama, S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol. 86, 6537-6545 (2012).
33. Kirchdoerfer, R.N. et al. Pre-fusion structure of a human coronavirus spike protein. Nature 531, 118-121 (2016).
34. McLellan, J.S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113-1117 (2013).
35. Yin, H.S., Wen, X., Paterson, R.G., Lamb, R.A., Jardetzky, T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439, 38-44 (2006).
36. Harrison, S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 15, 690-698 (2008).
37. Zheng, Q. et al. Core structure of S2 from the human coronavirus NL63 spike glycoprotein. Biochemistry 45, 15205-15215 (2006).
38. Dormitzer, P.R., Sun, Z.Y., Wagner, G., Harrison, S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21, 885-897 (2002).
39. Krempl, C., Schultze, B., Laude, H., Herrler, G. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J. Virol. 71, 3285-3287 (1997).
40. Milewska, A. et al. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J. Virol. 88, 13221-13230 (2014).
41. Peng, G. et al. Crystal structure of bovine coronavirus spike protein lectin domain. J. Biol. Chem. 287, 41931-41938 (2012).
42. Li, F. Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. J. Virol. 86, 2856-2858 (2012).
43. Wu, K., Li, W., Peng, G., Li, F. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc. Natl. Acad. Sci. USA 106, 19970-19974 (2009).
44. Reguera, J. et al. Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog. 8, e1002859 (2012).
45. Ying, T. et al. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat. Commun. 6, 8223 (2015).
46. Prabakaran, P. et al. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J. Biol. Chem. 281, 15829-15836 (2006).
47. Hwang, W.C. et al. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J. Biol. Chem. 281, 34610-34616 (2006).
48. Sui, J. et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA 101, 2536-2541 (2004).
49. Zhu, Z. et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclon al antibodies. Proc. Natl. Acad. Sci. USA 104, 12123-12128 (2007).
50. Chen, B. et al. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433, 834-841 (2005).
51. Huang, C.C. et al. Structure of a V3-containing HIV-1 gp120 core. Science 310, 1025-1028 (2005).
52. Stewart-Jones, G.B. et al. Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G. Cell 165, 813-826 (2016).
53. Sommerstein, R. et al. Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection. PLoS Pathog. 11, e1005276 (2015).
54. Falkowska, E., Kajumo, F., Garcia, E., Reinus, J., Dragic, T. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J. Virol. 81, 8072-8079 (2007).
55. Szakonyi, G. et al. Structure of the Epstein-Barr virus major envelope glycoprotein. Nat. Struct. Mol. Biol. 13, 996-1001 (2006).
56. Eckert, D.M., Malashkevich, V.N., Kim, P.S. Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residues. J. Mol. Biol. 284, 859-865 (1998).
57. Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41-60 (2005).
58. Rohou, A., Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216-221 (2015).
59. Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1-12 (2016).
60. Lander, G.C. et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 166, 95-102 (2009).
61. Voss, N.R., Yoshioka, C.K., Radermacher, M., Potter, C.S., Carragher, B. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J. Struct. Biol. 166, 205-213 (2009).
62. Scheres, S.H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519-530 (2012).
63. Lyumkis, D., Vinterbo, S., Potter, C.S., Carragher, B. Optimod: an automated approach for constructing and optimizing initial models for single-particle electron microscopy. J. Struct. Biol. 184, 417-426 (2013).
64. Scheres, S.H. Beam-induced motion correction for sub-megadalton cryo-EM particles. eLife 3, e03665 (2014).
65. Chen, S. et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24-35 (2013).
66. Goddard, T.D., Huang, C.C., Ferrin, T.E. Visualizing density maps with UCSF Chimera. J. Struct. Biol. 157, 281-287 (2007).
67. Emsley, P., Lohkamp, B., Scott, W.G., Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
68. DiMaio, F., Zhang, J., Chiu, W., Baker, D. Cryo-EM model validation using independent map reconstructions. Protein Sci. 22, 865-868 (2013).
69. Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21 (2010).
70. Agirre, J. et al. Privateer: software for the conformational validation of carbohydrate structures. Nat. Struct. Mol. Biol. 22, 833-834 (2015).
71. Lee, B., Richards, F.M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55, 379-400 (1971).
72. Dolinsky, T.J., Nielsen, J.E., McCammon, J.A., Baker, N.A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-W667 (2004).
73. Baker, N.A., Sept, D., Joseph, S., Holst, M.J., McCammon, J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98, 10037-10041 (2001).
74. Kucukelbir, A., Sigworth, F.J., Tagare, H.D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63-65 (2014).
75. Eng, J.K., Jahan, T.A., Hoopmann, M.R. Comet: an open-source MS/MS sequence database search tool. Proteomics 13, 22-24 (2013).
76. Raj, V.S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251-254 (2013).